Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

Innovative Eyewear Inc

LUCY · Nasdaq · CIK 0001808377 · Healthcare · Medical Instruments & Supplies

INSIDER SIGNAL

No active buy signal

0 qualifying P purchase groups
in the current 180-day scoring window

12 Form 4 transaction lines observed in the same window
7 sales · 5 option, withholding, award, gift or other lines

Last qualifying purchase2026-01-21 · Gross Harrison R. · $2.0K

WHY NO ACTIVE SIGNAL?

Purchase activityNone
Recent buyingNone
Recent salesModerate
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Cohen David EricChief Technology Officer
▼○▼
Gayle OswaldChief Financial Officer
○▼
Dabrowski KonradChief AI & Growth Officer
○▼
Abondano JoaquinChief Operating Officer
○▼
Gross Harrison R.Chief Executive Officer
○▼
● Purchase▼ Sale○ Other

—

Purchase breadth, concentration & cluster buying

These modules activate when qualifying purchases enter the 180-day research window.

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2026-01-21 · Gross Harrison R..

Recent Form 4 activity

21Purchases
13Sales
10Other Form 4 lines
15SEC filings · 365 days
BUYING0 qualifying P line(s) · 180 days
SELLING7 sale line(s) · context only
OTHER5 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
180,001
Previous report
158,090
Avg daily volume
189,566
Days to cover
≤ 1.0

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2026-01-21Gross Harrison R.Purchase (P)Common Stock1,500USD 1.32USD 1,980SEC filing ↗
2026-01-13Gayle OswaldPurchase (P)Common Stock1,000USD 1.67USD 1,669SEC filing ↗
2026-01-08Gross Harrison R.Purchase (P)Common Stock1,500USD 1.60USD 2,400SEC filing ↗
2026-01-08Dabrowski KonradPurchase (P)Common Stock1,300USD 1.58USD 2,054SEC filing ↗
2026-01-07Galkin VladimirPurchase (P)Common Stock, par value $0.00001643,505USD 1.79USD 1,151,874SEC filing ↗
2026-01-02Galkin VladimirPurchase (P)Common Stock, par value $0.000014,000USD 1.02USD 4,080SEC filing ↗
2026-01-02Galkin VladimirPurchase (P)Common Stock, par value $0.000011,262USD 0.97USD 1,224SEC filing ↗
2025-12-31Galkin VladimirPurchase (P)Common Stock, par value $0.0000189,830USD 0.99USD 88,932SEC filing ↗
2025-12-30Galkin VladimirPurchase (P)Common Stock, par value $0.0000111,303USD 1.08USD 12,207SEC filing ↗
2025-12-29Galkin VladimirPurchase (P)Common Stock, par value $0.0000146,107USD 1.10USD 50,718SEC filing ↗
2025-12-26Galkin VladimirPurchase (P)Common Stock, par value $0.0000190,709USD 1.22USD 110,665SEC filing ↗
2025-12-24Galkin VladimirPurchase (P)Common Stock, par value $0.00001928USD 1.31USD 1,216SEC filing ↗
2025-12-23Galkin VladimirPurchase (P)Common Stock, par value $0.0000132,958USD 1.33USD 43,834SEC filing ↗
2025-12-22Galkin VladimirPurchase (P)Common Stock, par value $0.00001367USD 1.35USD 495SEC filing ↗
2025-12-19Galkin VladimirPurchase (P)Common Stock, par value $0.000014,835USD 1.37USD 6,624SEC filing ↗

Form 4 evidence

44 transaction lines in the latest 365-day window; 143 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-08-19Gross Harrison R.Sale (S)Common Stock13,974USD 0.70USD 9,756SEC filing ↗
2026-08-19Gross Harrison R.Award / grant (A)Common Stock24,600USD 0.00USD 0SEC filing ↗
2026-08-19Gayle OswaldSale (S)Common Stock7,959USD 0.67USD 5,333SEC filing ↗
Show recent Form 4 evidence (30 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-08-19Gross Harrison R.Sale (S)Common Stock13,974USD 0.70USD 9,756SEC filing ↗
2026-08-19Gross Harrison R.Award / grant (A)Common Stock24,600USD 0.00USD 0SEC filing ↗
2026-08-19Gayle OswaldSale (S)Common Stock7,959USD 0.67USD 5,333SEC filing ↗
2026-08-19Gayle OswaldAward / grant (A)Common Stock16,233USD 0.00USD 0SEC filing ↗
2026-08-19Dabrowski KonradSale (S)Common Stock6,935USD 0.69USD 4,785SEC filing ↗
2026-08-19Dabrowski KonradAward / grant (A)Common Stock20,900USD 0.00USD 0SEC filing ↗
2026-08-19Cohen David EricSale (S)Common Stock6,136USD 0.68USD 4,172SEC filing ↗
2026-08-19Cohen David EricAward / grant (A)Common Stock18,200USD 0.00USD 0SEC filing ↗
2026-08-19Abondano JoaquinSale (S)Common Stock5,020USD 0.68USD 3,414SEC filing ↗
2026-08-19Abondano JoaquinAward / grant (A)Common Stock14,800USD 0.00USD 0SEC filing ↗
2026-07-06Cohen David EricSale (S)Common Stock1,860USD 1.17USD 2,176SEC filing ↗
2026-04-09Cohen David EricSale (S)Common Stock1,860USD 1.11USD 2,065SEC filing ↗
2026-04-02Gross Harrison R.Sale (S)Common Stock13,764USD 1.07USD 14,727SEC filing ↗
2026-04-02Gross Harrison R.Award / grant (A)Common Stock24,600USD 0.00USD 0SEC filing ↗
2026-04-02Gayle OswaldSale (S)Common Stock7,574USD 1.07USD 8,104SEC filing ↗
2026-04-02Gayle OswaldAward / grant (A)Common Stock16,233USD 0.00USD 0SEC filing ↗
2026-04-02Dabrowski KonradSale (S)Common Stock6,692USD 1.06USD 7,094SEC filing ↗
2026-04-02Dabrowski KonradAward / grant (A)Common Stock20,900USD 0.00USD 0SEC filing ↗
2026-04-02Cohen David EricSale (S)Common Stock5,913USD 1.04USD 6,150SEC filing ↗
2026-04-02Cohen David EricAward / grant (A)Common Stock18,200USD 0.00USD 0SEC filing ↗
2026-04-02Abondano JoaquinSale (S)Common Stock4,779USD 1.05USD 5,018SEC filing ↗
2026-04-02Abondano JoaquinAward / grant (A)Common Stock14,800USD 0.00USD 0SEC filing ↗
2026-01-21Gross Harrison R.Purchase (P)Common Stock1,500USD 1.32USD 1,980SEC filing ↗
2026-01-13Gayle OswaldPurchase (P)Common Stock1,000USD 1.67USD 1,669SEC filing ↗
2026-01-08Gross Harrison R.Purchase (P)Common Stock1,500USD 1.60USD 2,400SEC filing ↗
2026-01-08Dabrowski KonradPurchase (P)Common Stock1,300USD 1.58USD 2,054SEC filing ↗
2026-01-07Galkin VladimirPurchase (P)Common Stock, par value $0.00001643,505USD 1.79USD 1,151,874SEC filing ↗
2026-01-02Galkin VladimirPurchase (P)Common Stock, par value $0.000014,000USD 1.02USD 4,080SEC filing ↗
2026-01-02Galkin VladimirPurchase (P)Common Stock, par value $0.000011,262USD 0.97USD 1,224SEC filing ↗
2025-12-31Galkin VladimirPurchase (P)Common Stock, par value $0.0000189,830USD 0.99USD 88,932SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerLUCY
CIK0001808377
SectorHealthcare
IndustryMedical Instruments & Supplies Yahoo Finance
SEC SIC3851 Ophthalmic Goods
ExchangeNasdaq

Data coverage

Local Form 4 history143 transaction lines from 2024-08-19 to 2026-08-19
64 P purchase lines · 58 S sale lines · 21 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.